Free Press Release

FaceBook Page Twitter Feed
You are here: Home > Exclusive News > Health Point Inc. Announces Improved Genotyping Services

Health Point Inc. Announces Improved Genotyping Services

Posted Jul 27, 2014 by reginaldanderson
Health Point Inc. now offers dual matrix genotyping services which provide faster and more accurate genomic DNA extraction for mutation analysis, HLA genotyping, and Fc-gamma Receptor IIIa.

FOR IMMEDIATE RELEASE (Press Release) Jul 27, 2014 -- Dual matrix genotyping services are critical for reducing variation in sample populations to increase reproducibility in downstream applications. The improvement of genotyping is part of a wide ranging company strategy to increase facilities and variety of services.

Future expansion is expected to be funded by an initial public offering (IPO) which is planned for this year. More information will be released as it is made available through press releases and on the company website.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at and other sources before making any material decisions.
-- EOF ---
Contact Email :
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central
Country : Hong Kong SAR China
Categories : Business
Tags : health, Stem Cells, Research, Manufacture, Supply, Investment
Last Updated : Jul 27, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore